Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Schlegelberger B"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl.
Autorzy:
Göhring G; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Thomay K; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Schmidt G; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Ripperger T; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Xu M; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.; b Manitoba Institute of Cell Biology , CancerCare Manitoba , Winnipeg , Canada.
Wittner N; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Chao MM; c Department of Pediatric Hematology and Oncology , Hannover Medical School , Hannover , Germany.
Baumann I; d Department of Pathology , Clinical Center , Böblingen , Germany.
Niewisch M; e Division of Pediatric Hematology and Oncology, Department of Pediatrics , University Medical Center Freiburg , Freiburg , Germany.
Reinhardt D; f Clinic for Pediatrics III , University Hospital Essen , Essen , Germany.
Klingebiel T; g Hospital for Children and Adolescents , University Hospital Frankfurt , Frankfurt , Germany.
Thol F; h Department of Hematology, Hemostasis, Oncology and SCT , Hannover Medical School , Hannover , Germany.
Schlegelberger B; a Institute of Human Genetics , Hannover Medical School , Hannover , Germany.
Niemeyer CM; e Division of Pediatric Hematology and Oncology, Department of Pediatrics , University Medical Center Freiburg , Freiburg , Germany.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Mar; Vol. 58 (3), pp. 718-721. Date of Electronic Publication: 2016 Nov 28.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Clonal Evolution/*genetics
DNA (Cytosine-5-)-Methyltransferases/*genetics
Leukemia, Myeloid, Acute/*genetics
Myelodysplastic Syndromes/*genetics
Precancerous Conditions/*genetics
Adolescent ; Alleles ; Biomarkers ; Bone Marrow/pathology ; DNA Methylation ; DNA Methyltransferase 3A ; DNA Mutational Analysis ; Female ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukocyte Count ; Myelodysplastic Syndromes/diagnosis
Raport
Tytuł:
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.
Autorzy:
Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
Cruz MM; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Fabisch J; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Klesse S; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Köhler L; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Göhring G; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
Ganster C; Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany.
Shirneshan K; Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany.
Gutermuth A; Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany.
Cerny-Reiterer S; Department of Hematology and Hemostasis, Medical University Vienna, Vienna, Austria.
Krönke J; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.
Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Platzbecker U; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Thiede C; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Ehrlich S; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Stamer K; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Valent P; Department of Hematology and Hemostasis, Medical University Vienna, Vienna, Austria.
Schlegelberger B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
Kroeger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Haase D; Department of Hematology and Oncology, Georg-August-Universität Göttingen, Göttingen, Germany.
Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
Thol F; MLL Munich Leukemia Laboratory, Munich, Germany.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2015 Sep; Vol. 29 (9), pp. 1942-5. Date of Electronic Publication: 2015 Feb 24.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Deletion*
Chromosomes, Human, Pair 5*
Mutation*
Casein Kinase Ialpha/*genetics
Myelodysplastic Syndromes/*genetics
Myelodysplastic Syndromes/*mortality
Humans ; Prognosis
Raport
Tytuł:
Low frequency of calreticulin mutations in MDS patients.
Autorzy:
Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Fehse B; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alchalby H; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Badbaran A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Shahswar R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Stadler M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Eder M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Göhring G; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Trummer A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
Thiede C; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Platzbecker U; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Schlegelberger B; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Kroeger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2014 Sep; Vol. 28 (9), pp. 1933-4. Date of Electronic Publication: 2014 May 21.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Calreticulin/*genetics
Myelodysplastic Syndromes/*genetics
Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute/therapy ; Retrospective Studies ; Transplantation, Homologous
Raport
Tytuł:
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
Autorzy:
Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Markus B; Department of Cardiology, University Hospital Marburg, Marburg, Germany.
Fehse B; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alchalby H; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Badbaran A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lehmann U; Institute of Pathology, Hannover Medical School, Hannover, Germany.
Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Shahswar R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Chaturvedi A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Stadler M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Eder M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Göhring G; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Koenigsmann M; Outpatient Oncology Center Hannover, Hannover, Germany.
Kloos A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Trummer A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Thiede C; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Platzbecker U; Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany.
Schlegelberger B; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Kreipe HH; Institute of Pathology, Hannover Medical School, Hannover, Germany.
Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2014 Jul; Vol. 28 (7), pp. 1552-5. Date of Electronic Publication: 2014 Feb 07.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Calreticulin/*genetics
Primary Myelofibrosis/*genetics
Primary Myelofibrosis/*mortality
Graft vs Host Disease/etiology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Primary Myelofibrosis/therapy ; Prognosis ; Transplantation, Homologous ; Treatment Outcome
Raport
Tytuł:
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.
Autorzy:
Damm F
Thol F
Kosmider O
Kade S
Löffeld P
Dreyfus F
Stamatoullas-Bastard A
Tanguy-Schmidt A
Beyne-Rauzy O
de Botton S
Guerci-Bresler A
Göhring G
Schlegelberger B
Ganser A
Bernard OA
Fontenay M
Heuser M
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2012 May; Vol. 26 (5), pp. 1137-40. Date of Electronic Publication: 2011 Nov 08.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Myelodysplastic Syndromes/*genetics
Phosphoproteins/*genetics
Ribonucleoprotein, U2 Small Nuclear/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; RNA Splicing Factors ; Young Adult
Raport
Tytuł:
Update on cytogenetic and molecular changes in myelodysplastic syndromes.
Autorzy:
Schlegelberger B; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. schlegelberger. />Göhring G
Thol F
Heuser M
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2012 Apr; Vol. 53 (4), pp. 525-36. Date of Electronic Publication: 2011 Nov 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Chromosome Aberrations*
Mutation*
Genetic Predisposition to Disease/*genetics
Myelodysplastic Syndromes/*genetics
Humans ; Karyotype ; Myelodysplastic Syndromes/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia.
Autorzy:
Damm F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Bunke T
Thol F
Markus B
Wagner K
Göhring G
Schlegelberger B
Heil G
Reuter CW
Püllmann K
Schlenk RF
Döhner K
Heuser M
Krauter J
Döhner H
Ganser A
Morgan MA
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2012 Feb; Vol. 26 (2), pp. 289-95. Date of Electronic Publication: 2011 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
Biomarkers, Tumor/*genetics
Leukemia, Myeloid, Acute/*genetics
NADH Dehydrogenase/*genetics
Adult ; Base Sequence ; DNA Primers ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Nucleophosmin ; Polymerase Chain Reaction ; Prognosis ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies